These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 12878917)
1. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. COMBINE Study Research Group Alcohol Clin Exp Res; 2003 Jul; 27(7):1107-22. PubMed ID: 12878917 [TBL] [Abstract][Full Text] [Related]
2. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study. COMBINE Study Research Group Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918 [TBL] [Abstract][Full Text] [Related]
3. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A; JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409 [TBL] [Abstract][Full Text] [Related]
4. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study. Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934 [TBL] [Abstract][Full Text] [Related]
5. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M; J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059 [TBL] [Abstract][Full Text] [Related]
6. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Doggrell SA Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440 [TBL] [Abstract][Full Text] [Related]
8. Relationship between medication adherence and treatment outcomes: the COMBINE study. Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687 [TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA; Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638 [TBL] [Abstract][Full Text] [Related]
10. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R; J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346 [TBL] [Abstract][Full Text] [Related]
11. Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence. Swift R; Pettinati HM J Stud Alcohol Suppl; 2005 Jul; (15):141-7; discussion 140. PubMed ID: 16223065 [TBL] [Abstract][Full Text] [Related]
12. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A; Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666 [TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence. Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040 [TBL] [Abstract][Full Text] [Related]
14. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF; Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446 [TBL] [Abstract][Full Text] [Related]
15. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response. Gueorguieva R; Wu R; Krystal JH; Donovan D; O'Malley SS Addict Behav; 2013 May; 38(5):2119-27. PubMed ID: 23435273 [TBL] [Abstract][Full Text] [Related]
16. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Feeney GF; Connor JP; Young RM; Tucker J; McPherson A Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406 [TBL] [Abstract][Full Text] [Related]
17. Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder. Klemperer EM; Hughes JR; Naud S Drug Alcohol Depend; 2018 Sep; 190():229-234. PubMed ID: 30059816 [TBL] [Abstract][Full Text] [Related]
18. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Johnson BA; O'Malley SS; Ciraulo DA; Roache JD; Chambers RA; Sarid-Segal O; Couper D J Clin Psychopharmacol; 2003 Jun; 23(3):281-93. PubMed ID: 12826990 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous modeling of the impact of treatments on alcohol consumption and quality of life in the COMBINE study: a coupled hidden Markov analysis. Prisciandaro JJ; DeSantis SM; Bandyopadhyay D Alcohol Clin Exp Res; 2012 Dec; 36(12):2141-9. PubMed ID: 22551231 [TBL] [Abstract][Full Text] [Related]
20. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care. Ernst DB; Pettinati HM; Weiss RD; Donovan DM; Longabaugh R Ann Fam Med; 2008; 6(5):435-40. PubMed ID: 18779548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]